Equillium Inc (EQ)
1.67
+0.11
(+7.05%)
USD |
NASDAQ |
May 03, 16:00
1.69
+0.02
(+1.20%)
Pre-Market: 20:00
Equillium Total Assets (Quarterly): 50.53M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 50.53M |
| September 30, 2023 | 55.22M |
| June 30, 2023 | 58.76M |
| March 31, 2023 | 71.79M |
| December 31, 2022 | 78.42M |
| September 30, 2022 | 48.63M |
| June 30, 2022 | 62.47M |
| March 31, 2022 | 74.24M |
| December 31, 2021 | 85.40M |
| September 30, 2021 | 92.47M |
| June 30, 2021 | 99.84M |
| March 31, 2021 | 106.84M |
| Date | Value |
|---|---|
| December 31, 2020 | 85.43M |
| September 30, 2020 | 92.38M |
| June 30, 2020 | 44.26M |
| March 31, 2020 | 49.91M |
| December 31, 2019 | 55.54M |
| September 30, 2019 | 63.00M |
| June 30, 2019 | 57.89M |
| March 31, 2019 | 62.73M |
| December 31, 2018 | 67.16M |
| September 30, 2018 | 6.422M |
| June 30, 2018 | 6.728M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
44.26M
Minimum
Jun 2020
106.84M
Maximum
Mar 2021
70.16M
Average
63.00M
Median
Sep 2019
Total Assets (Quarterly) Benchmarks
| Janux Therapeutics Inc | 380.41M |
| Mersana Therapeutics Inc | 226.06M |
| Vera Therapeutics Inc | 175.55M |
| Jasper Therapeutics Inc | 94.89M |
| PepGen Inc | 143.05M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.96M |
| Shareholders Equity (Quarterly) | 22.57M |
| Current Ratio | 1.790 |
| Net Debt Paydown Yield | 3.24% |